Sequana Medical NV

ENXTBR:SEQUA Rapport sur les actions

Capitalisation boursière : €36.5m

Sequana Medical Résultats passés

Passé contrôle des critères 0/6

Sequana Medical's earnings have been declining at an average annual rate of -15.8%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 10% per year.

Informations clés

-15.8%

Taux de croissance des bénéfices

2.9%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie12.3%
Taux de croissance des recettes-10.0%
Rendement des fonds propresn/a
Marge nette-6,269.8%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

Health Check: How Prudently Does Sequana Medical (EBR:SEQUA) Use Debt?

Mar 19
Health Check: How Prudently Does Sequana Medical (EBR:SEQUA) Use Debt?

Did Sequana Medical's (EBR:SEQUA) Share Price Deserve to Gain 51%?

Jan 26
Did Sequana Medical's (EBR:SEQUA) Share Price Deserve to Gain 51%?

Do Institutions Own Sequana Medical NV (EBR:SEQUA) Shares?

Dec 03
Do Institutions Own Sequana Medical NV (EBR:SEQUA) Shares?

Ventilation des recettes et des dépenses

Comment Sequana Medical gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

ENXTBR:SEQUA Recettes, dépenses et bénéfices (EUR Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 240-27213
31 Mar 241-30243
31 Dec 231-33264
30 Sep 231-32274
30 Jun 231-32274
31 Mar 231-32264
31 Dec 221-31254
30 Sep 221-29244
30 Jun 221-27233
31 Mar 221-25223
31 Dec 210-24213
30 Sep 210-23193
30 Jun 210-21183
31 Mar 211-20172
31 Dec 201-19172
30 Sep 201-18162
30 Jun 201-17161
31 Mar 201-16151
31 Dec 191-15141
30 Sep 191-16122
30 Jun 191-16122
31 Mar 191-15112
31 Dec 181-14102
30 Sep 181-1091
31 Dec 171-881
31 Dec 161-14141
31 Dec 152-12121

Des revenus de qualité: SEQUA is currently unprofitable.

Augmentation de la marge bénéficiaire: SEQUA is currently unprofitable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: SEQUA is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.

Accélération de la croissance: Unable to compare SEQUA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: SEQUA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).


Rendement des fonds propres

ROE élevé: SEQUA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé